Skip to main content
Top
Published in: Modern Rheumatology 4/2010

01-08-2010 | Original Article

New low-field extremity MRI, compacTscan: comparison with whole-body 1.5 T conventional MRI

Authors: Takeshi Suzuki, Satoshi Ito, Shinya Handa, Katsumi Kose, Yoshikazu Okamoto, Manabu Minami, Makoto Sugihara, Masanobu Horikoshi, Hiroto Tsuboi, Taichi Hayashi, Daisuke Goto, Isao Matsumoto, Takayuki Sumida

Published in: Modern Rheumatology | Issue 4/2010

Login to get access

Abstract

Low-field extremity magnetic resonance imaging (lfMRI) is currently commercially available and has been used clinically to evaluate rheumatoid arthritis (RA). However, one disadvantage of this new modality is that the field of view (FOV) is too small to assess hand and wrist joints simultaneously. Thus, we have developed a new lfMRI system, compacTscan, with a FOV that is large enough to simultaneously assess the entire wrist to proximal interphalangeal joint area. In this work, we examined its clinical value compared to conventional 1.5 tesla (T) MRI. The comparison involved evaluating three RA patients by both 0.3 T compacTscan and 1.5 T MRI on the same day. Bone erosion, bone edema, and synovitis were estimated by our new compact MRI scoring system (cMRIS) and the κ coefficient was calculated on a joint-by-joint basis. We evaluated a total of 69 regions. Bone erosion was detected in 49 regions by compacTscan and in 48 regions by 1.5 T MRI, while the total erosion score was 77 for compacTscan and 76.5 for 1.5 T MRI. These findings point to excellent agreement between the two techniques (κ = 0.833). Bone edema was detected in 14 regions by compacTscan and in 19 by 1.5 T MRI, and the total edema score was 36.25 by compacTscan and 47.5 by 1.5 T MRI. Pseudo-negative findings were noted in 5 regions. However, there was still good agreement between the techniques (κ = 0.640). Total number of evaluated joints was 33. Synovitis was detected in 13 joints by compacTscan and 14 joints by 1.5 T MRI, while the total synovitis score was 30 by compacTscan and 32 by 1.5 T MRI. Thus, although 1 pseudo-positive and 2 pseudo-negative findings resulted from the joint evaluations, there was again excellent agreement between the techniques (κ = 0.827). Overall, the data obtained by our compacTscan system showed high agreement with those obtained by conventional 1.5 T MRI with regard to diagnosis and the scoring of bone erosion, edema, and synovitis. We conclude that compacTscan is useful for diagnosis and estimation of disease activity in patients with RA.
Literature
1.
go back to reference Cush JJ. Early rheumatoid arthritis—is there a window of opportunity? J Rheumatol Suppl. 2007;80:1–7.PubMed Cush JJ. Early rheumatoid arthritis—is there a window of opportunity? J Rheumatol Suppl. 2007;80:1–7.PubMed
2.
go back to reference Tamai M, Kawakami A, Uetani M, Takao S, Arima K, Iwamoto N, et al. A prediction rule for disease outcome in patients with undifferentiated arthritis using magnetic resonance imaging of the wrists and finger joints and serologic autoantibodies. Arthritis Rheum. 2009;61:772–8.CrossRefPubMed Tamai M, Kawakami A, Uetani M, Takao S, Arima K, Iwamoto N, et al. A prediction rule for disease outcome in patients with undifferentiated arthritis using magnetic resonance imaging of the wrists and finger joints and serologic autoantibodies. Arthritis Rheum. 2009;61:772–8.CrossRefPubMed
3.
go back to reference Taouli B, Zaim S, Peterfy CG, Lynch JA, Stork A, Guermazi A, et al. Rheumatoid arthritis of the hand and wrist: comparison of three imaging techniques. AJR Am J Roentgenol. 2004;182:937–43.PubMed Taouli B, Zaim S, Peterfy CG, Lynch JA, Stork A, Guermazi A, et al. Rheumatoid arthritis of the hand and wrist: comparison of three imaging techniques. AJR Am J Roentgenol. 2004;182:937–43.PubMed
4.
go back to reference Savnik A, Malmskov H, Thomsen HS, Bretlau T, Graff LB, Nielsen H, et al. MRI of the arthritic small joints: comparison of extremity MRI (0.2 T) vs high-field MRI (1.5 T). Eur Radiol. 2001;11:1030–8.CrossRefPubMed Savnik A, Malmskov H, Thomsen HS, Bretlau T, Graff LB, Nielsen H, et al. MRI of the arthritic small joints: comparison of extremity MRI (0.2 T) vs high-field MRI (1.5 T). Eur Radiol. 2001;11:1030–8.CrossRefPubMed
5.
go back to reference Yoshioka H, Ito S, Handa S, Tomiha S, Kose K, Haishi T, et al. Low-field compact magnetic resonance imaging system for the hand and wrist in rheumatoid arthritis. J Magn Reson Imaging. 2006;23:370–6.CrossRefPubMed Yoshioka H, Ito S, Handa S, Tomiha S, Kose K, Haishi T, et al. Low-field compact magnetic resonance imaging system for the hand and wrist in rheumatoid arthritis. J Magn Reson Imaging. 2006;23:370–6.CrossRefPubMed
6.
go back to reference Suzuki T, Ito S, Handa S, Kose K, Okamoto Y, Minami M, et al. A new low-field extremity magnetic resonance imaging and proposed compact MRI score: evaluation of anti-tumor necrosis factor biologics on rheumatoid arthritis. Mod Rheumatol. 2009;19:358–65.CrossRefPubMed Suzuki T, Ito S, Handa S, Kose K, Okamoto Y, Minami M, et al. A new low-field extremity magnetic resonance imaging and proposed compact MRI score: evaluation of anti-tumor necrosis factor biologics on rheumatoid arthritis. Mod Rheumatol. 2009;19:358–65.CrossRefPubMed
7.
go back to reference Handa S, Haishi T, Kose K. Development of a local electromagnetic shielding for an extremity magnetic resonance imaging system. Rev Sci Instrum. 2008;79:113706.CrossRefPubMed Handa S, Haishi T, Kose K. Development of a local electromagnetic shielding for an extremity magnetic resonance imaging system. Rev Sci Instrum. 2008;79:113706.CrossRefPubMed
8.
go back to reference Brown AK, Quinn MA, Karim Z, Conaghan PG, Peterfy CG, Hensor E, et al. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression. Arthritis Rheum. 2006;54:3761–73.CrossRefPubMed Brown AK, Quinn MA, Karim Z, Conaghan PG, Peterfy CG, Hensor E, et al. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression. Arthritis Rheum. 2006;54:3761–73.CrossRefPubMed
9.
go back to reference Brown AK, Conaghan PG, Karim Z, Quinn MA, Ikeda K, Peterfy CG, et al. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum. 2008;58:2925–7.CrossRef Brown AK, Conaghan PG, Karim Z, Quinn MA, Ikeda K, Peterfy CG, et al. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum. 2008;58:2925–7.CrossRef
10.
go back to reference Nishimoto N, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Azuma J. Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study. Ann Rheum Dis. 2009;68:1580–4.CrossRefPubMed Nishimoto N, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Azuma J. Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study. Ann Rheum Dis. 2009;68:1580–4.CrossRefPubMed
11.
go back to reference Bird P, Ejbjerg B, Lassere M, Østergaard M, McQueen F, Peterfy C, et al. A multireader reliability study comparing conventional high-field magnetic resonance imaging with extremity low-field MRI in rheumatoid arthritis. J Rheumatol. 2007;34:854.PubMed Bird P, Ejbjerg B, Lassere M, Østergaard M, McQueen F, Peterfy C, et al. A multireader reliability study comparing conventional high-field magnetic resonance imaging with extremity low-field MRI in rheumatoid arthritis. J Rheumatol. 2007;34:854.PubMed
Metadata
Title
New low-field extremity MRI, compacTscan: comparison with whole-body 1.5 T conventional MRI
Authors
Takeshi Suzuki
Satoshi Ito
Shinya Handa
Katsumi Kose
Yoshikazu Okamoto
Manabu Minami
Makoto Sugihara
Masanobu Horikoshi
Hiroto Tsuboi
Taichi Hayashi
Daisuke Goto
Isao Matsumoto
Takayuki Sumida
Publication date
01-08-2010
Publisher
Springer Japan
Published in
Modern Rheumatology / Issue 4/2010
Print ISSN: 1439-7595
Electronic ISSN: 1439-7609
DOI
https://doi.org/10.1007/s10165-010-0282-x

Other articles of this Issue 4/2010

Modern Rheumatology 4/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine